Clinical Trial Update: Intravenous Immunoglobulin for PANDAS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous immunoglobulin for PANDAS in children with obsessive-compulsive disorder has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Obsessive-compulsive Disorder
• Pandas

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Obsessive-Compulsive Disorder, Children | Phase 3 | Status: COMPLETED | Results posted: 2020-03-17